180 related articles for article (PubMed ID: 22742733)
21. Interleukin-13 receptor alpha 2 as a marker of poorer prognosis in high-grade astrocytomas.
Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Otsuka Y; Yamaguchi M; Ohnishi H; Ohtaki S; Noshiro S; Ookawa S; Mikami T; Mikuni N; Honmou O
J Neurosurg Sci; 2018 Jun; 62(3):239-244. PubMed ID: 28079349
[TBL] [Abstract][Full Text] [Related]
22. Minichromosome maintenance protein 3 elicits a cancer-restricted immune response in patients with brain malignancies and is a strong independent predictor of survival in patients with anaplastic astrocytoma.
Söling A; Sackewitz M; Volkmar M; Schaarschmidt D; Jacob R; Holzhausen HJ; Rainov NG
Clin Cancer Res; 2005 Jan; 11(1):249-58. PubMed ID: 15671553
[TBL] [Abstract][Full Text] [Related]
23. Expression of phosphoprotein enriched in astrocytes 15 kDa (PEA-15) in astrocytic tumors: a novel approach of correlating malignancy grade and prognosis.
Watanabe Y; Yamasaki F; Kajiwara Y; Saito T; Nishimoto T; Bartholomeusz C; Ueno NT; Sugiyama K; Kurisu K
J Neurooncol; 2010 Dec; 100(3):449-57. PubMed ID: 20455002
[TBL] [Abstract][Full Text] [Related]
24. [Radiotherapy of brain astrocytomas and oligodendrogliomas of the adult].
Mazeron JJ; Simon JM; Noël G; Proudhom MA; Renard A
Cancer Radiother; 2000 Nov; 4 Suppl 1():53s-66s. PubMed ID: 11194965
[TBL] [Abstract][Full Text] [Related]
25. Expression of autocrine motility factor mRNA is a poor prognostic factor in high-grade astrocytoma.
Tanizaki Y; Sato Y; Oka H; Utsuki S; Kondo K; Miyajima Y; Nagashio R; Fujii K
Pathol Int; 2006 Sep; 56(9):510-5. PubMed ID: 16930331
[TBL] [Abstract][Full Text] [Related]
26. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
[TBL] [Abstract][Full Text] [Related]
27. [Influence of phosphoglycerate kinase 1 on metastasis and invasion of hepatoma cells and prognosis of liver cancer].
Zhang L; Wang YC; Xie XY; Chen J; Gao DM; Ren ZG
Zhonghua Gan Zang Bing Za Zhi; 2017 Jun; 25(6):446-451. PubMed ID: 28763863
[No Abstract] [Full Text] [Related]
28. Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology.
Babu R; Bagley JH; Park JG; Friedman AH; Adamson C
J Neurosurg; 2013 Aug; 119(2):434-41. PubMed ID: 23662821
[TBL] [Abstract][Full Text] [Related]
29. Expression of CD133 as a Putative Prognostic Biomarker to Predict Intracranial Dissemination of Primary Spinal Cord Astrocytoma.
Inoue T; Endo T; Nakamura T; Shibahara I; Endo H; Tominaga T
World Neurosurg; 2018 Feb; 110():e715-e726. PubMed ID: 29180077
[TBL] [Abstract][Full Text] [Related]
30. Adult low-grade glioma: 19-year experience at a single institution.
Youland RS; Brown PD; Giannini C; Parney IF; Uhm JH; Laack NN
Am J Clin Oncol; 2013 Dec; 36(6):612-9. PubMed ID: 22892428
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the differential secretome of nasopharyngeal carcinoma cell lines CNE-2R and CNE-2.
Chen ZT; Li L; Guo Y; Qu S; Zhao W; Chen H; Su F; Yin J; Mo QY; Zhu XD
Oncol Rep; 2015 Nov; 34(5):2477-88. PubMed ID: 26352878
[TBL] [Abstract][Full Text] [Related]
32. The role of radiation therapy in the treatment of astrocytomas.
Leibel SA; Sheline GE; Wara WM; Boldrey EB; Nielsen SL
Cancer; 1975 Jun; 35(6):1551-7. PubMed ID: 1148989
[TBL] [Abstract][Full Text] [Related]
33. The role of FilGAP, a Rac-specific Rho-GTPase-activating protein, in tumor progression and behavior of astrocytomas.
Hara A; Hashimura M; Tsutsumi K; Akiya M; Inukai M; Ohta Y; Saegusa M
Cancer Med; 2016 Dec; 5(12):3412-3425. PubMed ID: 27790861
[TBL] [Abstract][Full Text] [Related]
34. SOX4 is overexpressed in diffusely infiltrating astrocytoma and confers poor prognosis.
Li L; Li Q; Chen X; Xu M; Li X; Nie L; Chen N; Gong J; Mao Q; Zhou Q
Neuropathology; 2015 Dec; 35(6):510-7. PubMed ID: 26096696
[TBL] [Abstract][Full Text] [Related]
35. Adult brain low-grade astrocytomas: survival after surgery and radiotherapy.
Arienti VM; Botturi A; Boiardi A; Broggi G; Collice M; Fariselli L; Zanni D; Botturi M
Neurol Sci; 2001 Jun; 22(3):233-8. PubMed ID: 11731876
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of Cathepsin D (CTSD) enhances radiosensitivity of glioblastoma cells by attenuating autophagy.
Zheng W; Chen Q; Wang C; Yao D; Zhu L; Pan Y; Zhang J; Bai Y; Shao C
Mol Carcinog; 2020 Jun; 59(6):651-660. PubMed ID: 32253787
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors in astrocytomas: relationship of p53, MDM-2, BCL-2 and PCNA immunohistochemical expression to tumor grade and overall patient survival.
Ehrmann J; Kolár Z; Vojtĕsek B; Kala M; Komenda S; Oulton A
Neoplasma; 1997; 44(5):299-304. PubMed ID: 9473789
[TBL] [Abstract][Full Text] [Related]
38. Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas.
Maris C; Rorive S; Sandras F; D'Haene N; Sadeghi N; Bièche I; Vidaud M; Decaestecker C; Salmon I
Neuropathol Appl Neurobiol; 2008 Jun; 34(3):316-29. PubMed ID: 17983425
[TBL] [Abstract][Full Text] [Related]
39. Intramedullary low-grade astrocytomas: long-term outcome following radical surgery.
Jallo GI; Danish S; Velasquez L; Epstein F
J Neurooncol; 2001 May; 53(1):61-6. PubMed ID: 11678433
[TBL] [Abstract][Full Text] [Related]
40. Immune-complex level of cofilin-1 in sera is associated with cancer progression and poor prognosis in pancreatic cancer.
Satoh M; Takano S; Sogawa K; Noda K; Yoshitomi H; Ishibashi M; Mogushi K; Takizawa H; Otsuka M; Shimizu H; Miyazaki M; Nomura F
Cancer Sci; 2017 Apr; 108(4):795-803. PubMed ID: 28161904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
